Brainsway Receives CE Approval for Its System to Treat Neuropathic Chronic Pain – Jewish Business News

by admin on May 30, 2013

Brainsway Receives CE Approval for Its System to Treat Neuropathic Chronic Pain
Jewish Business News
Brainsway Ltd. (TASE:BRIN) announced today that it has received CE Mark enabling commercialization of its Deep TMS system to treat neuropathic chronic pain (“neuropathic pain”) in the European Union and the countries in Asia and Latin America that

View full post on chronic pain – Google News

Previous post:

Next post: